日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study

维格列汀治疗2型糖尿病患者的胰腺安全性：一项欧洲非干预性上市后安全性研究

期刊:Endocrinology, Diabetes and Metabolism
影响因子:2.6
doi:10.1002/edm2.52
Williams, Rachael; Kothny, Wolfgang; Serban, Carmen; Lopez-Leon, Sandra; Schlienger, Raymond
糖尿病
代谢
发表日期：2019
文献求助 收藏

Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study

维格列汀与2型糖尿病患者血管性水肿、足部溃疡、皮肤损伤、肝毒性和严重感染风险之间的关联：一项欧洲多数据库、非干预性、上市后安全性研究

期刊:Endocrinology, Diabetes and Metabolism
影响因子:2.6
doi:10.1002/edm2.84
Williams, Rachael; Kothny, Wolfgang; Serban, Carmen; Lopez-Leon, Sandra; de Vries, Frank; Schlienger, Raymond
炎症/感染
皮肤损伤
代谢
糖尿病
毒理研究
发表日期：2019
文献求助 收藏

Long-term results of an anatomically implanted hip arthroplasty with a short stem prosthesis (MiniHip(TM))

采用短柄假体（MiniHip(TM)）进行解剖植入式髋关节置换术的长期结果

期刊:World Journal of Orthopedics
影响因子:2.3
doi:10.5312/wjo.v9.i10.210
von Engelhardt, Lars V; Breil-Wirth, Andreas; Kothny, Christian; Seeger, Jörn Bengt; Grasselli, Christian; Jerosch, Joerg
发表日期：2018
文献求助 收藏

Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies

种族和民族对维格列汀疗效的影响：II期和III期研究的汇总分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.12844
Kozlovski, Plamen; Fonseca, Marilia; Mohan, Viswanathan; Lukashevich, Valentina; Odawara, Masato; Paldánius, Päivi M; Kothny, Wolfgang
发表日期：2017
文献求助 收藏

Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial

维格列汀与西格列汀治疗2型糖尿病合并严重肾功能损害患者的疗效比较：一项随机临床试验

期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-015-3655-z
Kothny, Wolfgang; Lukashevich, Valentina; Foley, James E; Rendell, Marc S; Schweizer, Anja
糖尿病
代谢
发表日期：2015
文献求助 收藏

Efficacy and safety of a single-pill combination of vildagliptin and metformin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial

维格列汀和二甲双胍单片复方制剂治疗日本2型糖尿病患者的疗效和安全性：一项随机、双盲、安慰剂对照试验

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-015-0099-x
Odawara, Masato; Yoshiki, Mika; Sano, Misako; Hamada, Izumi; Lukashevich, Valentina; Kothny, Wolfgang
糖尿病
代谢
发表日期：2015
文献求助 收藏

Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea

维格列汀治疗二甲双胍和磺脲类药物联合治疗血糖控制不佳的2型糖尿病患者的疗效和安全性

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.12229
Lukashevich, V; Del Prato, S; Araga, M; Kothny, W
糖尿病
代谢
发表日期：2014
文献求助 收藏

Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trial

一项旨在确定早期使用维格列汀-二甲双胍联合方案与标准二甲双胍单药治疗相比，血糖控制持久性的研究——VERIFY试验：一项随机双盲试验

期刊:Diabetic Medicine
影响因子:3.4
doi:10.1111/dme.12508
Del Prato, S; Foley, J E; Kothny, W; Kozlovski, P; Stumvoll, M; Paldánius, P M; Matthews, D R
发表日期：2014
文献求助 收藏

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

维格列汀联合胰岛素治疗的临床证据和机制基础

期刊:Vascular Health and Risk Management
影响因子:2.8
doi:10.2147/VHRM.S40972
Schweizer, Anja; Foley, James E; Kothny, Wolfgang; Ahrén, Bo
免疫/内分泌
发表日期：2013
文献求助 收藏

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

维格列汀联合胰岛素治疗2型糖尿病合并严重肾功能损害患者的疗效

期刊:Vascular Health and Risk Management
影响因子:2.8
doi:10.2147/VHRM.S39300
Lukashevich, Valentina; Schweizer, Anja; Foley, James E; Dickinson, Sheila; Groop, Per-Henrik; Kothny, Wolfgang
代谢
糖尿病
免疫/内分泌
发表日期：2013
文献求助 收藏